Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 2Mycosis Fungoides 1Lymphomatoid Papulosis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Disease 1

Interventions

Peripheral Blood Stem Cell Transplantation 10Cyclosporine 9fludarabine phosphate 7Mycophenolic Acid 6Cyclophosphamide 6Whole-Body Irradiation 5Psychiatric Rehabilitation 4Filgrastim 4Antilymphocyte Serum 4Radiotherapy 3Methylprednisolone 3Methotrexate 3Melphalan 3Flow Cytometry 3Etoposide 3Busulfan 3Aprepitant 3Analgesia 3plerixafor 2Therapeutics 2Ondansetron 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Cord Blood Stem Cell Transplantation 2Calcium Dobesilate 2thymoglobulin 1peginterferon alfa-2b 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Mycosis Fungoides × Mechlorethamine × Clear all
NCT05303480 2023-01-25

Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides

Centre for Human Drug Research, Netherlands

Phase NA Completed
32 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡